GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (HKSE:02160) » Definitions » 3-Year EBITDA Growth Rate

MicroPort CardioFlow Medtech (HKSE:02160) 3-Year EBITDA Growth Rate : -16.20% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is MicroPort CardioFlow Medtech 3-Year EBITDA Growth Rate?

MicroPort CardioFlow Medtech's EBITDA per Share for the six months ended in Dec. 2023 was HK$-0.13.

During the past 3 years, the average EBITDA Per Share Growth Rate was -16.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 25.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of MicroPort CardioFlow Medtech was 88.10% per year. The lowest was -31.90% per year. And the median was -16.20% per year.


Competitive Comparison of MicroPort CardioFlow Medtech's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, MicroPort CardioFlow Medtech's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MicroPort CardioFlow Medtech's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort CardioFlow Medtech's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where MicroPort CardioFlow Medtech's 3-Year EBITDA Growth Rate falls into.



MicroPort CardioFlow Medtech 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


MicroPort CardioFlow Medtech  (HKSE:02160) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


MicroPort CardioFlow Medtech 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of MicroPort CardioFlow Medtech's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroPort CardioFlow Medtech (HKSE:02160) Business Description

Traded in Other Exchanges
Address
No. 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China.

MicroPort CardioFlow Medtech (HKSE:02160) Headlines

No Headlines